Regulatory T cells (Treg) quantification in HIV infection remains ill defined due to the lack of reliable specific markers to identify human Treg and the diversity of clinical stages of HIV infection.
INTRODUCTION
HIV infection is characterized by massive CD4 depletion, inefficient HIV specific immune responses and chronic immune hyper activation. Multiple mechanisms lead to dysfunctions of both HIV specific and non specific immune responses. In that respect, alterations of regulatory T cells (Treg) numbers and/or functions have been considered. Treg have been shown to exert suppressive activity during infectious immune responses 1 . However, the overall influence of Treg during HIV infection remains ill defined: Treg induced suppression may prove deleterious to the development of efficient HIV specific immune responses or beneficial by preventing inappropriate immune activation 2 . Suppressive activity of Treg on HIV specific responses has been repeatedly described [3] [4] [5] . However, very few consensual data are available concerning Treg functions and numbers during HIV infection. A strong suppressive activity of Treg has been initially associated to decreased viral load 3 but most studies point to a pathogenic role of Treg on HIV infection 4, 5 . Recently, CD8 T cells restricted by protective HLA alleles have been characterized by their capacity to evade Treg suppression, thus associating delayed disease progression and low Treg suppression 6 . It has also been demonstrated that Treg proliferate during HIV infection 7 and are directly targeted by HIV infection [8] [9] [10] . However, Treg quantification in HIV infection remains controversial in part due to the lack of reliable specific marker to identify human Treg. CD25 and to a lesser extent Foxp3 expression are transiently expressed by activated T cells, a bias especially deleterious in the context of chronic immune activation. These uncertainties in
Treg characterization led to conflicting data on the quantification of regulatory T cells 11 . Combination of CD127 low expression and CD25 or Foxp3 expression is currently used to enhance Treg characterization presumably by excluding effector non Treg cells 12, 13 . However, the purity of regulatory T cells reached using such strategy remains under debate 14 . This strategy also excludes a fraction of Treg which may include activated Treg as demonstrated in mice 15 . Importantly, heterogeneity in Treg quantification appears to differ depending on clinical stage of HIV infection.
Whereas Treg percentages are shown to be consistently increased in HIV infected patients with low CD4 count [16] [17] [18] [19] [20] [21] [22] 
Flow cytometry and regulatory T cells identification
Absolute Six-color flow cytometry was performed with a FACSCanto cytometer (BD Biosciences) and data files were analyzed using FlowJo software (Tree Star Inc.).
Peptide-human leukocyte antigen class 1 multimers and activation profile
HIV-specific CD8 + T cells were identified by using soluble PE-labeled or APC-labeled peptide-human 
Statistical Methods
Statistical analysis was performed using GraphPad prism software. Groups were compared using the nonparametric Kruskal Wallis test followed by Dunn's multiple comparison tests. Spearman's rank test was used to determine correlations. Pearson correlation curve were indicated when correlations were significant and guassian approximation validated.
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RESULTS

Decline in Treg numbers in all HIV infected patients studied
Miyara and Sakaguchi have developed a novel strategy allowing naïve and effector Treg identification using differential expression of CD45RA and Foxp3 staining 29 (Fig. 1A) . To fairly evaluate the relative advantages of both identification strategies in the context of HIV infection, we first analyzed "total" Treg defined by addition of naïve (CD45RA+Foxp3low) and effector (CD45RA-Foxp3hi) Treg compared to identification by Foxp3+CD25+CD127low expression on CD4 T cells (Fig. 1B and 1C, respectively). Regardless the identification strategy used, significant reduction in Foxp3 expressing CD4 T cells numbers was detected in all HIV infected groups compared to healthy donors.
Quantification of Treg by CD45RA and Foxp3 combination appears more stringent, but does not drastically modify the conclusion usually drawn on total Treg numbers during HIV: decline in Treg cell numbers was consistently detected in all HIV patients studied, in accordance with studies demonstrating HIV infection affected both Treg and conventional CD4 T cells. Collectively our data demonstrate that disruption of the Treg pool is long lasting and occurs in all groups of HIV infected patients studied.
Tregs percentages are reduced in primary HIV infected patients and HIV controllers
Reduction of Treg numbers may reflect the impact of HIV on all CD4 T cells. To determine whether
Tregs were differentially affected among CD4 T cells, we determined Treg percentages using each identification strategy. Percentages of Treg detected among CD4 T cells differed depending on the combination used: lower percentages were consistently recovered using CD45RA/Foxp3 combination compared to Foxp3+CD25+CD127low identification. However, both detection strategies revealed significant reduction in Treg percentages during primary infection and among HIV controllers compared to healthy donors (Fig. 2) , the lowest percentage being observed during primary infection.
No significant difference was observed in untreated viremic patients regardless the combination used.
Observations differed in ART treated patients who exhibited significant reduction in CD127lowCD25+Foxp3+ Treg percentage but no significant differences when using CD45RA/Foxp3 controllers, but not in untreated and ART treated patients using the more stringent definition.
Effector Treg are preferentially affected during HIV infection
We next analyzed naïve (CD45RA + Foxp3low) and effector (CD45RA -Foxp3hi) Treg fractions.
Although a slight reduction of naïve Treg numbers was detected in all groups, statistical reduction of naive Treg numbers was uniquely detected in primary HIV infected patients (Fig. 3A) . Importantly, no statistical differences were detected in naïve Treg percentages in all groups of HIV infected patients compared to healthy donors. In contrast, effector Treg absolute numbers were statistically reduced in all groups studied (Fig. 3B ). However percentages of effector Treg among CD4 T cells were solely statistically reduced in primary infected patients and HIV controllers. Collectively, analyses of naïve and effector Treg numbers suggested different outcome for naïve and effector Treg during HIV infection. Naïve Treg counts were affected during the early phase of infection (primary infected patients). In contrast, effector Treg numbers were consistently affected all along the course of HIV infection. Moreover, alteration in effector Treg numbers affected all groups of patients whereas alterations in percentages were less consistently detected. This suggests that quantification of Treg numbers is more sensible than quantification of percentages.
Correlation of effector Treg counts to CD4 count was lost in all HIV infected groups studied except in HIV controllers
To evaluate potential associations between Tregs and HIV related disease progression, we performed correlations between total, naïve and effector Tregs counts and CD4 count. When classical CD127lowCD25+Foxp3+ total Tregs identification was used, highly significant correlation was obtained between Tregs and CD4 count in healthy donors (p<0.0001) as well as in aviremic HIV patients (p=0.0005 in ART treated and p=0.0003 in HIV controllers) (Fig. 4A ). Conversely this
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correlation was lost in viremic patients both during primary infection (p=0.1727) and at the chronic stage (p=0.0628). When Treg subsets were considered ( Fig. 4B and 4C ), naïve or effector Treg counts were highly correlated to CD4 T cell count in healthy donors. In all groups of patients studied, correlation between naïve Treg count and CD4 count was observed (p=0.0306 PHI, 0.0152 VIR, 0.0037 ART and 0.0078 in HIC) (Fig. 4B) . In contrast, a significant correlation between effector Treg numbers and CD4 count was detected in HIV controllers (p=0.0026) whereas it was lost in untreated viremic (p=0.5715), in primary infected (p=0.9483) and ART treated (p=0.1941) patients.
Collectively, these data suggest that the relationship between naïve Treg and CD4 count is mildly affected during all HIV stages studied whereas effector Treg correlation to CD4 count is altered with the exception of HIV controllers.
Naïve Treg but not effector Treg counts inversely correlate with viral load
We next compared in viremic patients (including primary infected and untreated viremic patients) correlation obtained between CD127lowCD25+Foxp3+ Treg, naïve Treg and effector Treg counts and viral load. Using classical CD127lowCD25+Foxp3+ Treg identification, no significant correlation was obtained between Tregs and viral load (Fig. 5A) . However, significant inverse correlation was detected between viral load and naïve Treg, but not effector Treg numbers ( Fig. 5B and 5C ). These data confirm that discriminating between naïve and effector Treg provide additional information compared to total Treg characterization.
Inverse correlation between HIV specific CD8 T cell responses and effector Treg number
We numbers were consistently reduced in all groups of HIV infected patients studied when compared to healthy donors, as previously described 17, 18, 30 . Collectively, data obtained when using CD45RA/Foxp3 combination rather confirmed those observed with previous Treg identification strategy. Decrease in Treg percentages during primary HIV infection has been previously described 23 and may reflect Treg susceptibility to HIV infection 8, 10 or recruitment to inflamed sites [31] [32] [33] . When considering HIV controllers, decrease in Treg percentages and numbers compared to healthy donors has been previously demonstrated 27 .
We next evaluated whether naive/effector Treg distinction provided novel insight on Treg biology during HIV infection. We showed that naive and effector Treg count were differently affected during Treg/CD4 T cell ratio and Treg/CD8 T cell ratio.
We next attempted to evaluate the impact of effector Treg on HIV related disease progression. between Treg and immune activation have been so far extremely heterogeneous and contradictory presumably due to variability in identification strategies and clinical status 5, 24, 27, [39] [40] [41] [42] . In the present study, no significant correlation between effector Treg numbers (nor percentages) and non specific 
